You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lung SBRT, ESAS, anxiety

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer, Anxiety Post SBRT Trial in Toronto (CSRT led telephone follow up)

Withdrawn
  • Lung Cancer, Anxiety Post SBRT
  • CSRT led telephone follow up
  • Toronto, Ontario, Canada
    Sunnybrook Odette Cancer Centre
Nov 15, 2019

Lung Cancer, Radiotherapy, Stereotactic Body Radiotherapy Trial in Peking (SBRT)

Active, not recruiting
  • Lung Cancer
  • +3 more
  • SBRT
  • Peking, Beijing, China
    Department of radiation oncology, Peking University Third Hospit
Mar 26, 2023

Early Lung Cancer, Stereotactic Body Radiotherapy Trial in Peking (SBRT)

Not yet recruiting
  • Early Lung Cancer
  • Stereotactic Body Radiotherapy
  • SBRT
  • Peking, Beijing, China
    Department of radiation oncology, Peking University Third Hospit
Mar 26, 2023

NSCLC Metastatic Trial in Stockholm (Stereotactic body radiation therapy (SBRT), Temporary Stopping)

Recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Stereotactic body radiation therapy (SBRT)
  • Temporary Stopping
  • Stockholm, Solna, Sweden
    Karolinska University Hospital
Nov 9, 2023

NSCLC Without Mutation in Epidermal Growth Factor Receptor (Disorder) Trial (tereotactic body radiotherapy)

Not yet recruiting
  • Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)
  • tereotactic body radiotherapy
  • (no location specified)
Dec 1, 2023

Palliative Care, Pain Management, Anxiety Trial in Montréal, Saint-Georges (Personalized multimodal intervention involving

Recruiting
  • Palliative Care
  • +3 more
  • Personalized multimodal intervention involving hypnosis and/or music
  • Montréal, Quebec, Canada
  • +1 more
Jul 10, 2023

Oligometastases Trial in Baltimore (Nelfinavir, Stereotactic Body Radiation (SBRT))

Completed
Has Results
  • Oligometastases
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jun 14, 2021

Lung Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Lung Trial in Chicago (procedure, other,

Not yet recruiting
  • Lung Carcinoma
  • +5 more
  • Computed Tomography
  • +6 more
  • Chicago, Illinois
    Northwestern University
Mar 24, 2023

NSCLC, Stereotactic Body Radiotherapy, Comprehensive Geriatric Assessment Trial in Denmark (Comprehensive Geriatric Assessment)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Comprehensive Geriatric Assessment
  • Aarhus, Aarhus N, Denmark
  • +3 more
Jun 22, 2023

Lung Cancer, Left Sided Breast Cancer Trial in Cleveland (Continuous Positive Airway Pressure, Deep inspiratory breath hold,

Recruiting
  • Lung Cancer
  • Left Sided Breast Cancer
  • Continuous Positive Airway Pressure
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 17, 2023

Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Buffalo (Best Practice,

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +8 more
  • Best Practice
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 29, 2022

SBRT, NSCLC, Lung Metastasis Trial in Brest (Pre-therapeutic imaging test)

Active, not recruiting
  • SBRT
  • +2 more
  • Pre-therapeutic imaging test
  • Brest, Brest Cedex, France
    CHRU de Brest
Sep 16, 2022

Stage III Non-small-cell Lung Cancer Trial in Providence (Durvalumab, SBRT)

Recruiting
  • Stage III Non-small-cell Lung Cancer
  • Providence, Rhode Island
  • +1 more
Feb 23, 2022

Advanced Cancer Trial in Kuala Lumpur (Mindful breathing, Standard care (control))

Completed
  • Advanced Cancer
  • Mindful breathing
  • Standard care (control)
  • Kuala Lumpur, Malaysia
    University Malaya Medical Centre
Jun 9, 2023

Lung Tumor Malignant Trial in Milano (SBRT, Surgery)

Not yet recruiting
  • Lung Neoplasm Malignant
  • SBRT
  • Surgery
  • Milano, MI, Italy
    Istituto Europeo di Oncologia IRCCS
Jul 26, 2023

Lung Non-Small Cell Carcinoma, Malignant Solid Tumor, Melanoma Trial in Duarte (procedure, other, radiation)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Apr 13, 2023

NSCLC, NSCLC, Lung Cancer Trial in United States (Durvalumab, Stereotactic Body Radiation Therapy)

Recruiting
  • NSCLC
  • +7 more
  • Hartford, Connecticut
  • +8 more
Jul 7, 2022

Extensive-stage Small-cell Lung Cancer Trial in Pittsburgh (Durvalumab 50 MG/1 ML Intravenous Solution, Etoposide Injection,

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Durvalumab 50 MG/1 ML Intravenous Solution
  • +4 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 31, 2022

NSCLC Trial in Worldwide (Durvalumab, Placebo, Osimertinib (single-arm, open-label))

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Tuscaloosa, Alabama
  • +260 more
Dec 16, 2022

NSCLC Metastatic Trial in Chengdu (Camrelizumab, stereotactic body radiation therapy, Chemotherapy)

Recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Chengdu, Sichuan, China
    Sichuan Cancer Hospital & Institute
Jul 21, 2022

Lung Cancer, Surgery Trial in Montreal (Same Day Discharge - Video-Assisted Thoracoscopic Surgery (VATS) Lung)

Recruiting
  • Lung Cancer
  • Surgery
  • Same Day Discharge - Video-Assisted Thoracoscopic Surgery (VATS) Lung
  • Montreal, Quebec, Canada
    McGill University Health Centre
Oct 13, 2022

NSCLC Trial (Anlotinib Hydrochloride, penpulimab, SBRT)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Anlotinib Hydrochloride
  • +2 more
  • (no location specified)
Aug 2, 2022

Lung Cancer Trial in Toronto (EBUS-TBNA)

Recruiting
  • Lung Cancer
  • EBUS-TBNA
  • Toronto, Ontario, Canada
    Toronto General Hospital
Oct 31, 2022

Dyspnea, Malignant Tumor Trial in Houston (Dexamethasone, Placebo, Questionnaire Administration)

Active, not recruiting
Has Results
  • Dyspnea
  • Malignant Neoplasm
  • Houston, Texas
  • +2 more
Nov 29, 2022

Non Small Cell Lung Cancer, Stage IV NSCLC, Brain Metastases Trial in Hangzhou (Hypofractionated Stereotactic Radiotherap)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Hypofractionated Stereotactic Radiotherap
  • Hangzhou, China
    Kaicheng Pan
Oct 18, 2022